Skip to content

Association between Ambient PM2.5 Exposure and Comorbidity of Rosacea-Migraine: A Retrospective Clinical Study

Association between Ambient PM2.5 Exposure and Comorbidity of Rosacea-Migraine: A Retrospective Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128339
Enrollment
Unknown
Registered
2026-07-17
Start date
2026-07-20
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Rosacea with migraine group:None
Simple rosacea group:None

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients with first-time diagnosis of rosacea in the Department of Dermatology of our hospital, meeting the diagnostic criteria of the Chinese Guidelines for the Diagnosis and Treatment of Rosacea (2021 Edition); 2.Patients comorbid with migraine diagnosed in the Department of Neurology of our hospital, complying with the International Classification of Headache Disorders-3 (ICHD-3) criteria issued by the International Headache Society (IHS); 3.Continuous residence in Xuzhou for 1 year prior to diagnosis with complete environmental exposure data; 4.Complete medical records including clinical assessments, dermoscopic examinations and laboratory findings; 5.Aged 18–65 years, with no restriction on gender.

Exclusion criteria

Exclusion criteria: 1.Coexistence with other facial inflammatory dermatoses (e.g., acne, atopic dermatitis, psoriasis, lupus erythematosus); 2.Presence of primary or secondary headaches other than migraine; 3.Receipt of facial botulinum toxin injection, photoelectric therapy, or systemic administration of retinoids and glucocorticoids within 6 months before diagnosis; 4.Complicated with severe cardiac, hepatic, renal, hematological, autoimmune or psychiatric disorders; 5.Pregnant or lactating females; 6.Patients with irreparable missing key information in medical records.

Design outcomes

Primary

MeasureTime frame
Occurrence of rosacea complicated with migraine;PM2.5 exposure level;Core dermoscopic indicator score;

Countries

China

Contacts

Public ContactZhang Jingxi

The Affiliated Hospital of Xuzhou Medical University

dr.guanjiang@gmail.com+86 18168777336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026